Analysts keep high price targets on Dell (DELL)


Even after weak guidance and a 13% sell-off on Friday, Wall Street analysts still look for a rebound in Dell Inc. (NASDAQ: DELL) shares. That is, if you look at their ratings and price targets.

Thomson tracks 30 analysts who cover the stock and their average rating is a "buy" or a 2.43 on a scale of 1 to 5. Perhaps more stunning is that the price target that broker researchers have on the shares is over $33. The stock trades at $24.54.

Coverage on big cap stocks is notable for the fact that analysts do not like to put "sell" ratings on companies. For one thing, it may deny them access to company management. But, Dell is a bit of a special case.

With a fuzzy forecast of modest sales in the next quarter and Hewlett-Packard (NYSE: HPQ) taking global PC market share, it is hard to see how Dell can do much better, at least until the middle of next year. The company also has said that it may have more restructuring costs and that component costs are no longer falling fast.

Wall Street has it wrong on Dell.

Douglas A. McIntyre is an editor at 247wallst.com.

Symbol Lookup
IndexesChangePrice
DJIA-89.2312,801.23
NASDAQ-23.352,903.88
S&P 500-9.311,342.64

Last updated: February 10, 2012: 05:36 PM

Hot Stocks

General Electric

18.875-0.255(-1.33)

Alcoa

10.29-0.35(-3.29)

Apple Inc

493.42+0.25(+0.05)

Google Inc 'A'

605.91-5.55(-0.91)

Bank of America

8.07-0.11(-1.34)

Wal-Mart Stores

61.90-0.06(-0.10)

Exxon Mobil Corp

83.80-1.08(-1.27)

Ford

12.44-0.25(-1.97)

Citigroup

32.925-0.735(-2.18)

IBM

192.42-0.71(-0.37)

Yahoo

16.14+0.14(+0.88)

Starbucks

48.82-0.38(-0.77)

Microsoft

30.495-0.275(-0.89)

Home Depot

45.33+0.06(+0.13)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1328913367890 ms.